Mettler-Toledo International Inc. | Large-cap | Healthcare

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 3.9B
Gross Profit 2.3B 60.06%
Operating Income 1.1B 29.11%
Net Income 863.1M 22.29%

Balance Sheet Metrics

Total Assets 3.2B
Total Liabilities 3.4B
Shareholders Equity -126.9M

Cash Flow Metrics

Operating Cash Flow 960.3M
Free Cash Flow 864.4M

Revenue & Profitability Trend

Mettler-Toledo Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 3.9B 3.8B 3.9B 3.7B 3.1B
Cost of Goods Sold 1.5B 1.5B 1.6B 1.5B 1.3B
Gross Profit 2.3B 2.2B 2.3B 2.2B 1.8B
Operating Expenses 1.1B 1.1B 1.1B 1.1B 960.3M
Operating Income 1.1B 1.1B 1.1B 994.7M 784.0M
Pre-tax Income 1.0B 973.7M 1.1B 949.4M 748.7M
Income Tax 174.1M 185.0M 198.1M 180.4M 146.0M
Net Income 863.1M 788.8M 872.5M 769.0M 602.7M
EPS (Diluted) - $35.90 $38.41 $32.78 $24.91

Income Statement Trend

Mettler-Toledo Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.2B 1.2B 1.4B 1.3B 1.1B
Non-Current Assets 2.0B 2.1B 2.1B 2.1B 1.8B
Total Assets 3.2B 3.4B 3.5B 3.3B 2.8B
Liabilities
Current Liabilities 1.2B 1.2B 1.1B 1.1B 840.3M
Non-Current Liabilities 2.2B 2.3B 2.3B 2.0B 1.7B
Total Liabilities 3.4B 3.5B 3.5B 3.2B 2.5B
Equity
Total Shareholders Equity -126.9M -149.9M 24.8M 171.4M 282.7M

Balance Sheet Composition

Mettler-Toledo Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 863.1M 788.8M 872.5M 769.0M 602.7M
Operating Cash Flow 960.3M 1.0B 874.8M 808.2M 674.1M
Investing Activities
Capital Expenditures -102.3M -104.5M -120.8M -103.9M -89.4M
Investing Cash Flow -119.5M -131.7M -139.4M -314.1M -100.4M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -879.7M -878.8M -2.7B -2.6B -770.6M
Free Cash Flow 864.4M 860.6M 737.8M 801.2M 632.2M

Cash Flow Trend

Mettler-Toledo Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.82
Forward P/E 27.09
Price to Book -135.91
Price to Sales 6.26
PEG Ratio 27.09

Profitability Ratios

Profit Margin 22.17%
Operating Margin 25.19%
Return on Equity -680.23%
Return on Assets 21.22%

Financial Health

Current Ratio 1.01
Debt to Equity -11.40
Beta 1.39

Per Share Data

EPS (TTM) $40.04
Book Value per Share -$8.76
Revenue per Share $181.70

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
mtd 24.0B 28.82 -135.91 -680.23% 22.17% -11.40
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Idexx Laboratories 42.1B 48.33 29.21 59.33% 22.76% 73.16
Agilent Technologies 33.0B 28.60 5.37 18.88% 17.59% 60.04
Iqvia Holdings 27.4B 21.64 4.61 21.64% 8.61% 242.91

Financial data is updated regularly. All figures are in the company's reporting currency.